TLDR Spironolactone may reduce excessive hair growth in women.
In the 1990 study "Use of spironolactone in treatment of hirsutism", spironolactone was examined as a potential treatment for hirsutism, a condition characterized by excessive hair growth in women. The study found that spironolactone, a drug typically used to treat high blood pressure, was effective in reducing symptoms of hirsutism. The number of participants in the study was not specified. However, the results suggested that spironolactone could be a viable treatment option for hirsutism, although further research was recommended to confirm these findings and determine the optimal dosage and treatment duration.
3 citations,
January 2012 in “Hanyang Medical Reviews” The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.
85 citations,
June 2006 in “Best Practice & Research Clinical Endocrinology & Metabolism” The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.
47 citations,
March 2004 in “European journal of endocrinology” Spironolactone plus finasteride reduces hirsutism more effectively.
76 citations,
December 1997 in “Fertility and Sterility” Finasteride reduces hair growth better, but spironolactone has more side effects.
124 citations,
September 1980 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism” Spironolactone is effective in treating excessive hair growth in women.
